Virchow's triad
In the 1850s the German pathologist Rudolf Virchow studied clots that travel to the lungs, coined 'embolism' and described what makes blood clot: stasis, vessel injury and hypercoagulability (Virchow, 1856). Long sitting, surgery or fractures, cancer, pregnancy and estrogen all fit that frame. Unlike varicose veins, DVT is hidden deep in the leg.
Symptoms and the danger
Swelling, pain, warmth or redness in one leg are typical, though many clots are silent. Sudden breathlessness, sharp chest pain or coughing blood suggests pulmonary embolism: call emergency services (NHLBI, n.d.). Venous thromboembolism strikes roughly 1–2 per 1,000 adults a year in Western populations, and about 30% recur within 10 years (Heit, 2015).
Diagnosis and treatment
Doctors estimate pretest probability with the Wells score (Wells et al., 1997), use D-dimer to rule out low-risk cases and confirm with compression ultrasound. Treatment moved from heparin injections and warfarin to direct oral anticoagulants after trials such as EINSTEIN (2010). CHEST guidelines favor DOACs for most patients without cancer and at least three months of therapy (Kearon et al., 2016; Stevens et al., 2021).
Prevention
- On trips over four hours, walk every 1–2 hours and flex your ankles.
- Stay hydrated, limit alcohol.
- After surgery, move early and follow prevention advice.
- Keep a healthy weight (BMI) and do not smoke.
Arterial events such as heart attack and stroke differ but share many risk factors.
This article is general health information and is not a substitute for diagnosis or treatment. If symptoms persist, see a doctor.
FAQ
- Do I need compression socks for every flight?
- Not necessarily; they are mainly considered for people with risk factors. Walking and ankle exercises help everyone.
- Is any leg swelling a clot?
- No, but sudden one-sided swelling with pain or redness deserves prompt medical review.
Sources reviewed: 2026-11-02
References
- Virchow, R. (1856). Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Meidinger Sohn & Comp. Source of Virchow's triad of stasis, vessel injury and hypercoagulability.
- Wells, P. S., Anderson, D. R., Bormanis, J., Guy, F., Mitchell, M., Gray, L., Clement, C., Robinson, K. S., & Lewandowski, B. (1997). Value of assessment of pretest probability of deep-vein thrombosis in clinical management. The Lancet, 350(9094), 1795–1798. The Wells score for pretest probability.
- Heit, J. A. (2015). Epidemiology of venous thromboembolism. Nature Reviews Cardiology, 12(8), 464–474. Review of incidence, recurrence and risk factors.
- EINSTEIN Investigators. (2010). Oral rivaroxaban for symptomatic venous thromboembolism. The New England Journal of Medicine, 363(26), 2499–2510. Oral rivaroxaban matched standard therapy.
- Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., Stevens, S. M., Vintch, J. R. E., Wells, P., Woller, S. C., & Moores, L. (2016). Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest, 149(2), 315–352. CHEST guideline on drug choice and duration.
- Stevens, S. M., Woller, S. C., Kreuziger, L. B., Bounameaux, H., Doerschug, K., Geersing, G.-J., Huisman, M. V., Kearon, C., King, C. S., Knighton, A. J., Lake, E., Murin, S., Vintch, J. R. E., Wells, P. S., & Moores, L. K. (2021). Antithrombotic therapy for VTE disease: Second update of the CHEST guideline and expert panel report. Chest, 160(6), e545–e608. The 2021 update of the CHEST guideline.
- National Heart, Lung, and Blood Institute. (n.d.). Venous thromboembolism. NIH patient guide to symptoms and prevention.